Press Release: Creso Pharma Signs Agreement to Acquire Established Canadian Psychedelics Company Halucenex Life Sciences Inc.

CANNANNEW REPORT

• Halucenex is a Psychedelic-Assisted Psychotherapy (PAP) company ‍ • Halucenex focuses on the commercialisation and R&D of novel psychedelic… Read More….. The post Press Release: Creso Pharma Signs Agreement to Acquire Established Canadian Psychedelics Company Halucenex Life Sciences Inc. appeared first on Cannabis Law Report.

Excerpt only …
READ MORE BELOW
Source : Press Release: Creso Pharma Signs Agreement to Acquire Established Canadian Psychedelics Company Halucenex Life Sciences Inc.

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.